Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Mercurophylline [INN:BAN:NF]
RN: 8012-34-8
InChIKey: JTDRBSMSKQRBGT-UHFFFAOYSA-L

Note

  • Combination of Na salt of mercamphamidum & theophylline.

Classification Codes

  • Drug / Therapeutic Agent
  • Human Data
  • Organometallic

Molecular Formulas

  • C14-H24-Hg-N-O5.C7-H8-N4-O2.Na
  • C14-H25-Hg-N-O5.C7-H8-N4-O2.Na

Molecular Weight

  • 690.0918
 
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Mercamphamide mixture of sodium salt with theophlline
  • Mercurophylline
  • Mercurophylline [INN:BAN:NF]

Synonyms

  • A mixture of sodium salt of 3-(3-(hydroxymercuri)-2-methoxypropyl)camphoramic acid (C14H24HgNNaO5) and theophylline (C7H8N4O2)
  • Mercupurin
  • Mercurin
  • Mercurofilina
  • Mercurofilina [INN-Spanish]
  • Mercurophylline
  • Mercurophyllinum
  • Mercurophyllinum [INN-Latin]
  • Mercuzan
  • Mercuzanthin
  • Merthylline
  • Novurit
  • Novurite
  • Osmuryl

Systematic Names

  • A mixture of sodium salt of 3-(3-(hydroxymercuri)-2-methoxypropyl)camphoramic acid (C14H24HgNNaO5) and theophylline (C7H8N4O2)
  • Mercurate(1-), (3-(((3-carboxylato-2,2,3-trimethylcyclopentyl)carbonyl)amino)-2-methoxypropyl)hydroxy-, monosodium salt, mixt.with 3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione
  • Mercury, (3-(3-carboxy-2,2,3-trimethylcyclopentanecarboxamido)-2-methoxypropyl)hydroxy-, mixture with theophylline
  • Sodium (3-(((3-carboxylato-2,2,3-trimethylcyclopentyl)carbonyl)amino)-2-methoxypropyl)hydroxymer curate(1-), mixt. with 3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione

Registry Numbers

CAS Registry Number

  • 8012-34-8

System Generated Number

  • 0008012348

Molecular Formulas

Molecular Formulas

  • C14-H24-Hg-N-O5.C7-H8-N4-O2.Na
  • C14-H25-Hg-N-O5.C7-H8-N4-O2.Na

Molecular Formula Fragments

  • C14-H24-Hg-N-O5
  • C14-H25-Hg-N-O5
  • C7-H8-N4-O2
  • COMPONENT
  • Na

Structure Descriptors

InChI

1S/C14H24NO4.C7H8N4O2.Hg.Na.H2O/c1-9(19-5)8-15-11(16)10-6-7-14(4,12(17)18)13(10,2)3;1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;;;/h9-10H,1,6-8H2,2-5H3,(H,15,16)(H,17,18);3H,1-2H3,(H,8,9);;;1H2/q-1;;+2;+1;/p-2

InChIKey

JTDRBSMSKQRBGT-UHFFFAOYSA-L

Smiles

CC1(C(CCC1(C)C(=O)[O-])C(=O)NCC([CH2-])OC)C.Cn1c2c(c(=O)n(c1=O)C)[nH]cn2.[OH-].[Na+].[Hg+2]

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
cat LDLo intravenous 250mg/kg (250mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 99, Pg. 149, 1950.
human TDLo intravenous 28mg/kg (28mg/kg) CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION) JAMA, Journal of the American Medical Association. Vol. 117, Pg. 1806, 1941.
mouse LD50 intravenous 1410mg/kg (1410mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 99, Pg. 149, 1950.
mouse LD50 subcutaneous 163mg(Hg)/kg (163mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 105, Pg. 336, 1952.
rabbit LDLo intravenous 177mg/kg (177mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 99, Pg. 149, 1950.
rat LD50 intraperitoneal 121mg/kg (121mg/kg)   Therapie. Vol. 10, Pg. 936, 1955.